Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Pancreatic Neoplasms 15Neoplasms 11Multiple Myeloma 9Colorectal Neoplasms 8Myelodysplastic Syndromes 7Leukemia, Myeloid, Acute 6Glioblastoma 5Sarcoma 4Prostatic Neoplasms 4Neoplasms, Plasma Cell 4Leukemia, Myelomonocytic, Chronic 4Carcinoma, Non-Small-Cell Lung 4Inflammation 3Breast Neoplasms 3Stomatitis 2Stomach Neoplasms 2Skin Neoplasms 2Primary Myelofibrosis 2Ovarian Neoplasms 2Neoplasms by Site 2Myofibroma 2Myeloproliferative Disorders 2Lymphoma 2Lung Neoplasms 2Liver Neoplasms 2Leukemia 2Glioma 2Frailty 2Digestive System Neoplasms 2Digestive System Diseases 2

Interventions

fludarabine phosphate 21Cyclophosphamide 20Peripheral Blood Stem Cell Transplantation 19Busulfan 16Tacrolimus 14Whole-Body Irradiation 12Methotrexate 12Mycophenolic Acid 11Cyclosporine 11Antilymphocyte Serum 10fludarabine 6Filgrastim 6peginterferon alfa-2a 5ruxolitinib 4Radiotherapy 4Methylprednisolone 4Melphalan 4Flow Cytometry 4Etoposide 4Decitabine 4Aspirin 4Stem Cell Transplantation 3Injections 3Cytogenetic Analysis 3Cytarabine 3Biopsy 3Azacitidine 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3merphos 2aldesleukin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thrombocythemia, Essential × Ascorbic Acid × Clear all
NCT01014546 2022-07-22

Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

Roswell Park Cancer Institute

Phase 1 Terminated
5 enrolled
Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡